Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ingvar A et al. – This study provides evidence that Aza treatment, but not cyclosporine treatment, is strongly associated with post–transplant CSCC risk. The results suggest that the risk of CSCC after organ transplantation is not only an effect of the immunosuppressive load per se.

Related Articles

Aerosolized vancomycin for the treatment of MRSA after lung transplantation
Respirology, 11/10/09    Relevance Score: 94%

Pre-transplant lung function is predictive of survival following pediatric bone marrow transplantation
Pediatric Blood & Cancer, 11/05/09    Relevance Score: 94%

Soluble CD30 Levels in Recipients Undergoing Heart Transplantation Do Not Predict Post-transplant Outcome
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 94%

Factors influencing liver transplant length of stay at two large-volume transplant centers
Liver Transplantation, 11/03/09    Relevance Score: 93%

Fulminant Hepatic Failure due to Varicella Zoster in a Heart Transplant Patient: Successful Liver Transplant
The Journal of Heart and Lung Transplantation, 10/28/09    Relevance Score: 93%

Today in Clinical Pharmacology...keeping you current

Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment
Journal of Allergy and Clinical Immunology, 11/25/09

Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma
Journal of Allergy and Clinical Immunology, 11/25/09

High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations
Journal of Allergy and Clinical Immunology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address